Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort
United European Gastroenterology Journal · 2025
DOI: 10.1002/ueg2.70102 ↗Kurz gefasst
Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Giulia Peduzzi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Università di Pisa.
Abstract (Originalsprache)
Background
The incidence of pancreatic ductal adenocarcinoma (PDAC) is lower in females than males (19.0 vs. 20.2 for 100,000 individuals in Europe). This disparity is commonly attributed to differences in exposure to lifestyle risk factors such as smoking and alcohol consumption; however, hormonal activity may also play a role.
Objective
This study aimed to comprehensively examine the role of hormone exposure and reproductive factors in males and females in PDAC susceptibility.
Methods
We analyzed 816 PDAC cases and 302,645 controls from the UK Biobank prospective cohort. Twenty hormone‐related variables and a polygenic risk score (PRS) were examined in females and males using epidemiological methods and machine learning algorithms.
Results
Oral contraceptives (OC) use increased PDAC risk (OR = 2.17 (95% CI: 1.70–2.80), p = 8.16 × 10 −10 ), while each full‐term pregnancy decreased it (OR = 0.83 (95% CI: 0.76–0.90), p = 2.60 × 10 −5 ). In males increased level of sex hormone‐binding globulin (SHBG) was associated with a decreased risk (OR = 0.98, 95% CI: 0.97–0.98, p = 7.38 × 10 −10 ). The machine learning model performed well in both sexes, with AUCs of 0.95 and 0.92, specificity of 0.86 and 0.92 and sensitivity of 0.90 and 0.81 for females and males, respectively. The use of an explainer identified age and the PRS as significant features for both sexes, with additional factors such as age at menopause and OC use for females, and SHBG concentration in blood for males.
Conclusion
We observed a consistent protective effect of the factors that decrease‐the exposure to menstrual cycle related hormones. Additionally, exogenous hormones increase due to long exposure to OC and HRT increases the risk of the disease. Therefore, our result suggests that it is more important to which hormones an individual is exposed compared to the overall increase or decrease in exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, University of Pisa, Pisa, Italy.
- Classe di Scienze, Scuola Normale Superiore, Pisa, Italy.
- Pancreato-Biliary Endoscopy and Endosonography Division, Pancreas Translational and Clinical Research Centre, San Raffaele Scientific Institute IRCCS, Vita-Salute San Raffaele University, Milan, Italy.
- Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
ORCID-Profile: Giulia Peduzzi, Federico Canzian
Förderung
- Università di Pisa
Zitieren
APA
Peduzzi, G., Pellungrini, R., Archibugi, L., Canzian, F., Rizzato, C., Capurso, G., & Campa, D. (2025). Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70102
Vancouver
Peduzzi G, Pellungrini R, Archibugi L, Canzian F, Rizzato C, Capurso G, et al. Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.70102
BibTeX
@article{Peduzzi2025,
author = {Peduzzi, Giulia and Pellungrini, Roberto and Archibugi, Livia and Canzian, Federico and Rizzato, Cosmeri and Capurso, Gabriele and Campa, Daniele},
title = {Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort},
journal = {United European Gastroenterology Journal},
year = {2025},
doi = {10.1002/ueg2.70102}
}
EUVIMED